Back to results
US 2001/0034344 A1Published application
Use of known agonists of the central cannabinoid receptor CB1
AssigneeBayer Aktiengesellschaft
InventorsJoachim Mittendorf, Jurgen Dressel, Michael Matzke, Jurgen Franz, Peter Spreyer, Verena Vohringer, Joachim Schuhmacher, Arno Friedl, Ervin Horvath, Frank Mauler, Jean-Marie-Viktor De Vry, Reinhard Jork
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of known agonists of the central cannabinoid receptor CB1 for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy and craniocerebral trauma.
Claims10
Use of known agonists of the cannabinoid receptor CB1 for the prophylaxis and treatment of neurodegenerative disorders, in particular of cerebral apoplexy and craniocerebral trauma.
Dependencies are inferred from the claim text.